Drug · DIN 00042579
MAXIDEX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 19, 2018; first marketed December 31, 1966.
- Drug Identification Number (DIN)
- 00042579
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Ointment
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Dexamethasone S01BA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXAMETHASONE | 0.1 % | W/W |
Other DINs named MAXIDEX
- DIN 00042560 · Marketed